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qualitative evaluation of an online pledge-
based system focused on making better
use of antibiotics
Joanna May Kesten1,2*, Alex Bhattacharya3, Diane Ashiru-Oredope3, Maya Gobin1,4 and Suzanne Audrey5Abstract
Background: The Antibiotic Guardian Campaign was developed to increase commitment to reducing Antimicrobial
Resistance (AMR), change behaviour and increase knowledge through an online pledge system for healthcare
professionals and members of the public to become Antibiotic Guardians (AG). This qualitative evaluation aimed to
understand AG experiences of the campaign and perceived impact on behaviour.
Methods: Ninety-four AGs (48 via a survey and 46 who had agreed to future contact) were invited to participate in
a telephone semi-structured interview. The sample was based on self-identification as a healthcare professional or a
member of the public, pledge group (e.g. adults, primary care prescribers etc.), pledge and gender. Interviews
explored how participants became aware of the campaign, reasons for joining, pledge choices, responses to joining
and views about the campaign’s implementation. Interviews were analysed using the Framework Method.
Results: Twenty-two AGs (10 healthcare professionals and 12 members of the public) were interviewed. AGs became
aware of the campaign through professional networks and social media, and were motivated to join by personal and
professional concern for AMR. Choice of pledge group and pledge were attributed to relevance and potential impact
on AMR and the behaviour of others through pledge enactment and promotion of the campaign. Most AGs could not
recall their pledge unprompted. Most felt they fulfilled their pledge, although this reflected either behaviour change or
the pledge reinforcing pre-existing behaviour. The campaign triggered AGs to reflect on AMR related behaviour and
reinforced pre-existing beliefs. Several AGs promoted the campaign to others. Responding collectively as part of the
campaign was thought to have a greater impact than individual action. However, limited campaign visibility was
observed and the campaign was perceived to have restricted ability to reach those unaware of AMR.
Conclusions: AGs were motivated to reduce AMR and most felt they fulfilled their pledges although for many this
appeared to be through reinforcement of existing behaviours. We recommend that the campaign engages those
without pre-existing knowledge of AMR by increasing its visibility, capitalising on the diffusion of its message and
including more awareness-raising content for those with limited AMR knowledge.
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Antimicrobial resistance (AMR), the process of bacteria
and other pathogens evolving to become resistant to
drugs and medicines, is a significant public health con-
cern [1] worsened by the inappropriate use of antibi-
otics [1]. The use of antimicrobials is informed by a
number of complex interacting factors including aware-
ness of appropriate antimicrobial use, expectations of
antimicrobial prescription and communication between
healthcare professionals and patients [2]. In the 2013
Eurobarometer report on AMR, 52% of those surveyed
in the UK correctly replied that antibiotics do not kill
viruses, however colds and flu were amongst the five
leading reasons for taking antibiotics [3] suggesting
there is a mismatch between knowledge and behaviour.
Increasing understanding of the consequences of
inappropriate antibiotic use has been highlighted as
important for creating a social norm for antibiotics to
be seen as a “last resort” p6 [4].
It is clear that multi-level action, targeting healthcare
providers and members of the public [2], is needed to
“prevent overuse, misuse and abuse” (p76) of antimicro-
bials [5]. “Responsible use” policy interventions to address
AMR attempt to “ensure that patients receive the right
treatment at the right time, use these drugs appropriately
and benefit from them” (p285) [6]. Public awareness cam-
paigns are one type of responsible use intervention to im-
prove the public’s knowledge of suitable antibiotic use and
causes of AMR. Educational interventions targeting the
public and healthcare professionals are recommended in
the World Health Organisation (WHO) strategy for con-
taining AMR [2]. It is difficult to assess the effects of pub-
lic health campaigns on AMR, antibiotic consumption
and prescribing, however a review of campaigns suggests
they can contribute to improved antibiotic use [7].
The European Antibiotic Awareness Day (EAAD),
which takes place annually on 18th November, aims to
increase awareness about the threat of AMR to public
health and encourage appropriate antimicrobial use [8].
The EAAD is supported by a website, social media and
various educational materials [8] and has received wide-
spread support from participating countries [6].
As part of the 2014 EAAD, an online pledge system
called the Antibiotic Guardian (AG) Campaign, was
launched in September in the United Kingdom (UK) to
increase people’s commitment to reduce AMR [9].
Public Health England (PHE) and the British Society for
Antimicrobial Chemotherapy developed the initial con-
cept for the AG website design and logo and provided
funding for the website development. The development
of the campaign was led by PHE in collaboration with a
multidisciplinary committee of animal and human health
professionals and representation from members of the
public across the UK from 26 organisations. Thecampaign was publicised by the PHE AMR and commu-
nications team, through free social media and press re-
lease promotions, and promoted by a volunteer network
of organisations including representatives from the NHS
(primary and secondary care), directors of public health,
local authority health and wellbeing boards and profes-
sional organisations.
A detailed description of the campaign has been pub-
lished previously [10, 11]. Briefly, AGs choose from a
number of pledge groups as either a ‘Healthcare profes-
sional or leader’ (e.g. Primary Care Prescribers, Nurses,
Dentists etc.) or ‘Member of the public’ (e.g. Adults, Fam-
ilies and Pet Owners etc.) (Fig. 1). Within the pledge
groups AGs select one pledge from lists offering between
three and eight options (Additional file 1). The campaign
website includes a video, aimed at the public, and written
resources explaining the AMR issue. The initial target of
10,000 pledges by 30th November 2014 was achieved and
in April 2017 the total number of pledges was ~46,000.
The campaign extends the EAAD goal of raising aware-
ness and seeks to change behaviour through the use of
pledges and support for collective action or responsibility
(identifying as an AG, visiting the website and being part of
a group of AGs) by addressing the intention-behaviour gap
in relation to the appropriate use of antibiotics [12]. The
intention-behaviour gap describes a situation in which an
individual is committed to a goal but does not achieve it. It
has been suggested that this gap can be addressed by sup-
porting people to translate goal intentions into behavioural
action in an “if-then” format [13]. For example, one of the
campaign’s pledges is “For infections that our bodies are
good at fighting off on their own, like coughs, colds, sore
throats and flu, I pledge to try treating the symptoms for
five days rather than going to the GP” (General Practi-
tioner). Setting implementation intentions increase the like-
lihood of goal attainment by supporting the automatic
trigger of certain actions in pre-determined situations [14].
Meta-analyses of experimental studies have shown medium
to large positive effects (d = 0.65) of implementation inten-
tions on goal attainment [15] and medium to large changes
(d=0.66) in behavioural intentions has shown small to
medium changes (d=0.36) in behaviour [16]. Pledges have
been recommended in a literature review and behavioural
analysis of behaviour change and antibiotic prescribing [4]
and have been employed in a number of other situations to
support behaviour change [17–20]. The evaluation of previ-
ous public campaigns addressing appropriate antibiotic use
have either been absent or variable in quality [7].
The NIHR Health Protection Research Unit in
Evaluation of Interventions was commissioned by PHE
to conduct a mixed methods evaluation of the AG
campaign to assess whether its goals were achieved.
The quantitative component of this evaluation [10]
analysed 2478 AG responses to an online
Fig. 1 Antibiotic Guardian Campaign website: pledge group and pledges (http://antibioticguardian.com/)
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of the campaign, assessing self-reported knowledge
and behaviour after joining the campaign. This evalu-
ation found self-reported evidence for an increase in
AG knowledge about and commitment to addressing
AMR, behaviour change in line with pledges after
joining the campaign and willingness to promote the
campaign to others [10]. PHE conducted a quantita-
tive process evaluation to examine the reach of the
campaign in its first 6 months (August 2014 to
January 2015) and found that the majority of AGs
identified as female (61%) and healthcare professionals
(69%) [11].
The aim of this qualitative evaluation is to provide a
more detailed understanding of participants’ views and
experiences of the campaign and the perceived impact
on behaviours related to AMR including health seeking
behaviours and antibiotic consumption.Methods
Sample and data collection
Semi-structured interviews were conducted to elicit un-
derstanding of AGs views and experiences of the cam-
paign. Due to the geographical spread of AGs across the
UK, one-to-one telephone interviews were the chosen
method of data collection. The sample size was deter-
mined pragmatically with an initial target of approxi-
mately 30 AGs (~15 ‘members of the public’ and ~15
‘healthcare professionals or leaders’). A third option,
‘Student or Educator’, was added later in the campaign:
Students were previously included within both ‘Members
of the public’ and ‘Healthcare professional or leader’, but
the Educator group was new to the campaign and was
not included in this evaluation. Within the pledge
groups we sought to achieve a sample with a range of
self-selected pledges and a gender balance similar to the
main AG cohort. A purposive sampling strategy was
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sample reflecting the AG cohort. In addition, a meta-
analysis has found that women are more likely to receive
an antibiotic prescription than men in primary care sug-
gesting that there are gender differences in antibiotic
prescribing behaviours which may translate into different
interactions with the campaign [21].
AGs were invited in small batches via email and
provided with participant information sheets between
August 2015 and January 2016 (10–16 months after
the campaign launch). If an invitation was declined,
or no response received, another individual was
invited with similar characteristics.
AGs were recruited for interview from two samples of
the main AG cohort. Sample 1 consisted of 57 AGs who
had agreed to receive an invitation to a qualitative study
when they were sent the questionnaire as part of the
quantitative evaluation (n = 9016, 0.63% response rate).
Within this sample, 63% selected pledges as ‘healthcare
professionals or leaders’ and 37% as ‘members of public’.
Eight AGs were excluded as their postcode indicated
they were non-UK residents, and one was excluded for
not selecting a pledge. Of the 48 eligible individuals, 10
‘members of the public’ and eight ‘healthcare
professionals’ were interviewed (38% recruitment rate)
(Additional file 2). To increase the sample size and rep-
resentation of pledge groups, in Sample 2 we purposively
sampled from those who had agreed to be contacted
about their pledge in the future when they joined the
campaign (n = 46) (Additional file 2). This yielded an
additional four AGs (8.7% recruitment rate) representing
pledge groups not recruited in Sample 1 (farmers, pet
owners, primary care prescribers and students).
The interview topic guide explored how AGs became
aware of the campaign, reasons for signing up, the
choice of pledge group and pledge, and responses to be-
coming an AG including the extent to which the pledge
was followed. In particular, the evaluation sought to
understand if AGs changed their approach to managing
illness (either personally or for family members or pa-
tients), their use or prescription of antibiotics and
whether they promoted the campaign to others. Lastly,
AGs were asked to reflect on the overall impact and
value of the campaign in the UK and to feedback on the
campaign’s content and design.
Verbal informed consent was audio recorded using an
encrypted recording device from all participants before
the interview. This approach minimised participant
burden by avoiding the inconvenience of returning (by
either post or email) written informed consent forms
before the interview. Written and verbal consent are
ethically comparable. The University of Bristol, Faculty
of Health Sciences granted exemption from requiring
ethical permission for this service evaluation.Analysis
Interviews were transcribed verbatim and anonymised.
The Framework Method [22], a form of thematic ana-
lysis, was undertaken with the support of QSR NVivo
Version 10. Analysis began with a process of ‘familiarisa-
tion’ with the audio recordings and transcripts. Initial
codes, which summarise and interpret the data, were
then systematically applied to the first few transcripts by
the main coder (JK) and a second coder (SA). These ini-
tial codes were iteratively refined and combined to pro-
duce an agreed coding framework which was applied to
all the remaining transcripts. As new or redundant infor-
mation was identified during this process, revisions were
made to the coding framework. The coded data was
then inserted into a Framework matrix in NVivo which
plots the codes against each participant. The volume of
data was condensed and summarised by theme and sub-
theme for each transcript. These summaries captured
the meanings in the data and included illustrative
quotes. Summarising the data in the matrix facilitated
interpretation of the data [22]. This method was selected
to facilitate reflections on salient themes, and similar or
divergent perspectives between participants [22].
Results
Twenty-two AGs representing a diverse range of pledge
groups including 12 ‘members of the public’ and 10
‘healthcare professionals or leaders’ were interviewed
(Table 1). This represents a recruitment rate of 23.4%
(22 out of 94 invited). Secondary care prescribers and
nurses were not represented in the sample. The mean
interview length was 51.8 min (range 29 to 116 min). In
the past year, antibiotics had been used personally by
seven AGs and by a family member of six. Five AGs had
prescribed or administered antibiotics (e.g. to livestock)
in the past year (Table 1). Six healthcare professional
AGs were unable to prescribe antibiotics in their role (2
AIPs, pharmacist, podiatrist, student, vet). The recruited
sample had a higher proportion of female AGs (81%)
and a lower proportion of HCPs (45.4%) compared to
those invited (77.6% female, 70.2% HCP) and the total
population of AGs described in the quantitative process
evaluation (61% female, 69% HCP) [11].
The four main themes and associated subthemes are
presented in Table 2. Each theme is described below and
supported by anonymised quotes with participant de-
scriptors of pledge group, gender and interview number.
Campaign awareness
Most AGs struggled to remember where they had heard
about the campaign and suggested a number of channels
through which they may have become aware of it includ-
ing professional networks (e.g. email invitations), and
social media.
Table 1 Interview participant characteristics
Antibiotic Guardian Campaign pledge group N
Members of the public 12
Adult 8
Families 2
Farmer 1
Pet owner 1
Healthcare professional 10
Antimicrobial/Infection Prevention and Control Specialists (AIP) 2
Dentist 2
Student (medical) 1
Other healthcare provider (podiatrist) 1
Pharmacist 1
Primary care prescriber 1
Vet 2
Gender
Male 4
Female 18
Use of antibiotics in the past yeara
Yes (personal) 5
Yes (family member or livestock) 4
Yes (prescribed antibiotics) 2
Yes (personal and family) 1
Yes (personal, family and prescribed) 1
Yes (prescribed and family) 1
No use or prescription of antibiotics 12
Total 22
aSix AGs pledged as healthcare professionals but were unable to prescribe
antibiotics in their current role (2 AIPs, pharmacist, podiatrist, student, vet)
Table 2 Qualitative themes and subthemes
Themes Subthemes
Campaign
awareness
• Employer and professional networks
• Invitation (e.g. via email)
• Social media
• Can’t remember
• News bulletins
• Radio
Campaign
decision
making
Reasons for signing up and initial impressions
• Interest / concern about AMR
• Lack of awareness / interest in
raising awareness of AMR
• Pre-existing knowledge of correct use of antibiotics
• Moral duty and personal responsibility
• Willingness and ability to help
• Furthering career/professional interest
• Likened to signing a petition
• Blame felt regarding antibiotic resistance
• Failure of current messages to change mind sets
• Access and use campaign promotional materials
• Previous illness experience
• Minimal effort / easy to sign up
Pledge group
• Most pertinent / relevant
• Qualifying for more than one group
• Ability to have an impact
• Other pledge group suggested
Pledge choices
• Pledge matched behaviour already performed
• Relevance of pledge
• Greatest perceived impact
• More than one pledge relevant
• Specific pledge feedback
• Different or amended pledges preferred/suggested
• Simplicity/clarity of information
• Age of child
• Breadth of pledge
Pledge recall N/A
Impact of
campaign
• Limited personal impact of campaign
• Value of the campaign
• Number of people signed up
• Raised awareness
• Reduced antibiotic use
• Unintended consequences
• Time needed for impact
• Reduced antibiotic resistance
• Reducing workload of GP
• Reaching a wider audience
• Visibility of campaign
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organisations, so the British Society of Antimicrobial
Chemotherapy, PHE. (Antimicrobial/Infection
Prevention and Control Specialists (AIP) Female
Interview 18)
Campaign decision making
The campaign requires AGs to make a number of
decisions; firstly, whether to join the campaign and
subsequently which pledge group and pledge to select.
Reasons for signing up and initial impressions
The majority of AGs were motivated to join the
campaign by their pre-existing interest and concern
about AMR related issues.
My reason comes from being a vet, in that I’m
concerned that antimicrobials will be removed from
the veterinary sector, and I believe it’s important that
we need to use them properly, because animals needthem as much as humans to avoid affecting animal
welfare. So it came from that - is that I want to keep
antimicrobial use with animals and not just being
reserved for humans. (Vet Female Interview 13)Well I thought it [the campaign] was about over
prescribing and over use and I totally agree that
something needs to be done because if you keep using
antibiotics at the rate we are they will not do us any
good. (Adult Female Interview 4)
AGs agreed with the message behind the campaign
and wanted to “play their part” and set a good example
for others. The campaign was perceived as encouraging
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For example, one AG likened it to the “Big Society” UK
government initiative in which a larger proportion of re-
sponsibility for running society is devolved to local com-
munities and volunteers. Responding collectively as part
of the campaign was anticipated to have a greater impact
than individual action.
I’d love to do something about it [AMR], but it’s really
hard when you’re just one person [laughs]. So signing
up to campaigns like this sort of does make you think,
right, okay, well it’s sort of demonstrating that the
general public does actually care about these things.
(Families Female Interview 5)I think it’s because when I was looking at it and thinking
that it was such a good idea that people were taking
responsibility for their own actions and that we could
all be part of it – I suppose it’s feeding into this kind of
Big Society idea – I thought, if I just look at this and
don’t actually do it, then that makes me worse than if I
didn’t do it ‘cause I wasn’t aware of it. So I felt I needed
to actually take an action from it because it is
something which is so important and it is something
that I agree with, so I thought (…) it’s almost like signing
one of these petitions. (Adult Female Interview 11)
As described in the extract above, the campaign was
likened to signing a petition and the number of pledges
was equated to the effectiveness and importance of both
the campaign and the AMR issue. By joining the
Campaign, AGs hoped the campaign would grow and
increase its impact.
Because a bit like signing a petition, (…) the bigger a
group of people there are who are even silently
campaigning about this, even if it’s the fact that they
don’t use antibiotics themselves (…) it’s just getting the
numbers up to show that this is such an important
cause. (Adult Female Interview 7)I guess the reality is the more people who sign up, the
wider it will spread. (Pet owner Female Interview 21)
There was a perception among AGs that the general
public were not fully aware of the AMR issue, did not
take the issue seriously enough and continued to use an-
tibiotics inappropriately. Therefore the campaign was
viewed as an important method of increasing awareness
of AMR issues.
I support the concept that antibiotics should not be
prescribed willy-nilly. I’m opposed to GPs over-
prescribing on all sorts of levels and I think the morepeople are aware of the potential risks of over-
prescribing, inappropriate prescribing, the better.
(Adult Male Interview 6)
In addition to a personal interest, several AGs viewed
joining the campaign as part of their professional role.
A sense of being blamed for AMR motivated the farmer
to join the campaign. The primary care prescriber also
disagreed with media coverage which blamed GPs for
AMR and an Antimicrobial/Infection Prevention and
Control Specialists (AIP) was aware of GPs feeling
blamed for AMR. The campaign was valued for its in-
clusivity and that it did not blame any groups for in-
appropriately using antibiotics.
Coming from an industry which is often rather
unfairly maligned as being one of the reasons why
we’ve got a problem with antibiotics I felt it was
particularly important for us to speak out.
(Farmer Male Interview 20)I feel a bit peeved that [media] headlines might well
read that GPs are doing it [overprescribing antibiotics
and contributing to AMR] because I don’t think we
are. I mean, you know, I think there are a lot of
contributing factors but I don’t think GP prescribing is
the sole problem (Primary Care Prescriber Female
Interview 22)This is a campaign for everybody, it makes everybody
feel that it’s not just gonna blame you know, one side
blame the other, which I know has happened a little
bit in the past. (Vet Female Interview 13)
Pledge group and pledge choices
Several AGs were eligible for more than one pledge
group but the website asked them to select one. AGs
chose the pledge group, and their pledge, based on its
relevance and likely impact. For some this meant choos-
ing to pledge as part of a wider social or professional
group (e.g. dentist, families etc.) rather than within the
‘adult’ pledge group as this was expected to possess
greater influence on the awareness and behaviour of
others. For example, promoting the campaign to others
through their professional or social networks and
encouraging appropriate antibiotic use.
I thought, well, there’s no point in signing up just for
myself because it’s nothing that I wouldn’t have done
anyway. To pledge for my family means that I’m
taking into consideration my son and sort of playing
into the bigger picture rather than just like, ‘Oh, my
God, my son is ill, therefore the doctor should give him
antibiotics’. (Families Female Interview 5)
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advocacy than the others to promote this campaign cos
I was meeting people who were more likely to be
needing antibiotics cos I’m in an environment where
antibiotics are used, so I felt like it was more pertinent.
(Medical student Male Interview 19)
Some AGs described choosing a pledge which
required a change to their behaviour, while others
commented that their pledge aligned with their
current behaviour. However, the AIP AG felt that
making such a pledge reinforced and added credibility
to their actions.
I do the first [pledge to consider drainage for dental
infections before using antibiotics] anyway, so I could
do more good by telling other people about it [pledge
to encourage clients/patients and colleagues to become
Antibiotic Guardians], so that was the pledge I chose.
(Dentist Female Interview 12)I think probably I was doing it before but it kind of,
you know, in a way because it’s become a much more
public thing it [the campaign] almost gives me the
right to challenge and encourage people to do this, so,
you know, this is brilliant because I can sort of hang it
on there and just say look, you know, this, this is really
important and, you know, if you go to this website then
you can think about what sort of pledge you’d like to
make, I can use that (…) as one way of, you know,
somebody doing something, you know, physically doing
something to support it. (AIP Female Interview 17)
The majority of pledges were perceived by AGs to be
clear, appropriate, comprehensive and relevant. For ex-
ample, the pledge recommending treating symptoms for
5 days rather than visiting a GP was generally approved
of in relation to the length of time.
It’s not been five days yet, so I’m gonna wait five days
and then I’m gonna go.’ So I think it’s been helpful for
that aspect as well, that it’s given me something to
work with. (Adult Female Interview 11)
However, there were mixed responses to the pledge:
“For infections that our bodies are good at fighting off
on their own, like coughs colds sore throats and flu, I
pledge to talk to my pharmacist about how to treat the
symptoms first rather than going to the GP”. While
some AGs described fulfilling this pledge and perceiving
benefits to this approach, others felt that they did not re-
quire advice on treating symptoms of minor illnesses but
would visit a GP for more severe symptoms because they
are able to test for infections and prescribe medication.[If] I feel I have a chest infection, which is kind of
going above and beyond, the pharmacist is not gonna
be able to help me with that. I’m gonna have to go to
the GP. I was thinking, I’m unlikely to do that one
because I would either not go or I’d need to go to the
GP. (Adult Female Interview 11)
In relation to the pledge about safely disposing of
leftover antibiotics, some AGs (adults and pharmacist)
questioned why there would be leftover antibiotics as
the full course should be taken. Although there was
also some recognition that people either save leftover
antibiotics for a future infection (Farmer Male Inter-
view 20), already take leftover antibiotics to the
pharmacist (Adult Female Interview 11) or have left-
over antibiotics when a healthcare professional advises
the patient to take prescribed antibiotics only if needed
(Adult Female Interview 13).
Usually antibiotics are prescribed as a full course, so
the part about returning any unused antibiotics, I
would want them to return it to a pharmacy but I’d
want to find out why it was not used in the first place.
(Pharmacist Female Interview 15)
Pledge recall
Despite an automated email and certificate being sent to
all AGs thanking them for participating in the campaign
and listing their pledge, the majority could not recall
which pledge they had selected and only five could ei-
ther roughly or fully remember their pledge. For those
who could not remember, the interviewer (JK) informed
the AG of their pledge before continuing to discuss their
choices and the perceived impact of the campaign.
I know exactly what the campaign is for but I’m
struggling to say specifically which pledge I signed up
for. (Medical student Male Interview 19)
Impact of campaign
The campaign’s impact was discussed at the individual
and broader society (UK wide) level and in relation to its
visibility and reach.
Fulfilling the pledge
The majority of AGs felt they had fulfilled their pledge.
The extent to which pledges could be fulfilled was at-
tributed to a number of factors including: pledges
matching pre-existing behaviour; not having an oppor-
tunity to fulfil the pledge (e.g. not having relevant symp-
toms since joining the campaign), and; consciously
acting in line with pledges (e.g. promoting the campaign
to others). Acting in line with the pledge was described
by the farmer as an ongoing endeavour. A ‘families’ AG
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ABC song while washing their hands felt the pledge had
“really worked” and had become part of their hand
washing routine. One dentist and the primary care pre-
scriber perceived the campaign to have contributed to
auditing prescribing practice and adherence to prescrib-
ing guidelines. The primary care prescriber also per-
ceived the campaign as contributing to on-going
changes in the way they prescribe and to a reduced use
of antibiotics.
I haven’t been unwell, you know, in the last twelve
months where I’ve thought ‘oh I need to, you know, I
need to go and see the pharmacist.’
(Adult Female Interview 8)I’ve probably continued down a pathway and a trend
that I’d already started (...) with reducing the number
of [prescribed] antibiotics.
(Primary Care Prescriber Female Interview 22)
Raising and reinforcing awareness
There were mixed reports of the campaign informing
AGs about AMR. Some AGs described learning new in-
formation including the scale of the AMR issue while
others had learnt little and felt the campaign was a
continuation of their current thinking.
I think it’s confirmed what I already know which is
always useful because sometimes you can think you
know something and you’ve kind of come adrift a bit
or of course things change (…) It’s confirmed that what
I do is actually the right course of action.
(Pet owner Female Interview 21)
The campaign had prompted AGs to reflect on their
personal as well as others’ antibiotic use, and the issue of
AMR in general, and maintained their interest in the
topic. The campaign reinforced pre-existing beliefs
around not taking antibiotics, including refusing them
when offered, and led to AGs being more vigilant of
others practice. The campaign was also seen as a useful
support for professional activities such as teaching
medical and dentistry students.
It’s something I’ve believed for a long time becoming a
guardian just emphasised that fact - when there is a
suggestion of needing an antibiotic it’s probably made
me stronger about not taking the antibiotic.
(Adult Female Interview 7)
Promoting the campaign to others
Several AGs had promoted the campaign and its
messages to colleagues, students, patients, members ofthe public, friends and family through informal conver-
sations, lectures, emails, social media and by displaying
promotional materials (e.g. posters, certificates and
campaign statistics). The campaign was experienced by
a few AGs as empowering them to encourage and dis-
cuss the issues of the campaign with others. A couple
of AGs added the campaign logo and slogan to their
email signature, and an AIP AG’s organisation had
designed a computer screen saver promoting the
campaign and the EAAD.
I did forward it to people at work and said, ‘I’ve just
done this. Are you guys gonna sign up?’ So I was trying
to sort of do it that way, via e-mail, for people, so I
thought that was a good way to get other people
involved in it as well. (Adult Female Interview 11)It’s [campaign certificate displayed on wall of
consulting room] a useful reminder for patients, so
when I start the ‘look this is a viral infection and it’s
not gonna be helped by antibiotics’ I can point to it.
(Primary Care Prescriber Female Interview 22)It’s more of a sort of a mental feeling that I’m probably
more likely to be involved in discussions around
antibiotic resistance, because if someone says, “Oh,
what are you doing about it?”, I can say, “Well,
actually, I’m signed up, you know - Antibiotic
Guardian.” So I have mentioned it to people, that I’m
signed up to do it. (Adult Female Interview 11)
Collective action
The campaign was also described as encouraging collect-
ive action ensuring that everyone is “singing from the
same hymn sheet” and playing their part.
In contrast, two AGs commented that the campaign
did not feel like a collective response because it was too
selective in how it was promoted.
I was hoping I was going to become part of a really,
really proactive campaign that would get out to the
general public more, rather than it seems to be
healthcare professionals and people like that that
mainly sign up to it and are mainly aware of it. I
don’t see too many people, the general public sort of
signing up for it, as I say, I talk to a lot of people and
they’re just not even aware of it, which is a shame. I
think it’s been too, I dunno, selective in where it’s being
promoted. (Adult Female Interview 9)
Limited personal impact of campaign
For AGs who perceived themselves as aware of AMR
and appropriate antibiotic use, and as acting in line with
the selected pledges, the campaign was perceived to have
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that they were not the most appropriate target for the
campaign and that the campaign is “preaching to the
converted.” In addition, a few AGs perceived the cam-
paign to be limited to a day (EAAD). Many had not
returned to the website after signing up. Further, an AIP
AG had experienced negative feedback from GP’s who
viewed the campaign as patronising - “teaching granny
to suck eggs.”
I’m not sure I have used it, per se. As I say, I was
already very much anti-antibiotic prescribing on a
willy-nilly basis, and being an Antibiotic Guardian
(…) or putting my name to the campaign was (1)
enforcing the campaign, if you like, by swelling its
numbers, (2) giving me a medium which I can refer
people to, and (3) I suppose, giving me a sense of
gravitas if people would challenge what I was saying.
(Adult Male Interview 6)I’m probably already sitting at the end of your bell
curve for desirable antibiotic behaviour, so maybe I’m
not the right person to be signing these pledges.
(Adult Female Interview 3)Unintended consequences
The medical student commented that the campaign
should be careful not to discourage people from seeing
the GP when they need to. Indeed, one AG described
experiencing feelings of guilt for taking antibiotics after
signing up.
You have to be careful with that because some people
are more vulnerable and doing kind of like advice to
the whole public could, you wouldn’t want to prevent
someone seeing a doctor who actually should see them.
(Medical Student Male Interview 19)Wider impact
While the aims of the campaign were viewed as valuable,
several AGs were uncertain about its wider impact.
However, it was expected to take time for any measur-
able effects to develop.
I think the value of the campaign’s aims are immense
(…) for me, apart from, like I said, those few days
when I signed up and occasionally when I get
reminders about it when I get sent a survey, I couldn’t
honestly say that I’d seen the campaign itself have
much impact. (Adult Female Interview 3)
The limited number of pledges displayed on the
Campaign’s website, compared with the population as awhole, was interpreted as an estimate of its impact by
AGs.
Researcher: What impact do you feel the campaign is
having in the UK?Participant: Negligible, I would have thought, at that
number [of pledges]. (Adult Male Interview 6)
It was suggested that the campaign might reduce anti-
biotic use and AMR and reduce the workload of GP’s by
encouraging patients to visit a pharmacist instead.
Well if it makes people think ‘do I need to go to a
doctor?’ So right away you’re saving on the doctor’s
time. Appointments are being freed for people who
need them. You’re also saving on the fact that well
they haven’t needed the antibiotics, or they went to the
pharmacist who is very well qualified to deal with
many ailments. (Adult Female Interview 4)
Visibility of the campaign
The campaign and supporting materials were viewed as
having poor visibility and the majority of participants
had not seen the campaign publicised since joining. The
primary care provider was the only AG who described
receiving regular email communication about the
campaign.
The campaign was quite – ‘contained’ is the word I’m
going to use - and you would think that for something
so important they should’ve gone all bells whistling in
the media and everything, you know, but it isn’t.
(Pharmacist Female Interview 15)
Several strategies were suggested to increase the
reach and publicity of the campaign including: social
media promotion; leaflets and posters displayed in doc-
tors’ surgeries, veterinary practices and hospital A&E
departments, and; word of mouth communication from
HCPs, both about the campaign and prudent use of an-
tibiotics. These measures were suggested to help in-
form members of the public. An additional strategy
suggested was to develop a system for nominating
others to join the campaign.
It’d be good if you could nominate people [laughs], like
the Ice Bucket Challenge - have it going through like
that - ‘cause there’s definitely a couple of people that
could do with taking this pledge, that I’m aware of. So
it’s really hard, ‘cause I suppose it doesn’t do the
campaign much good if the people that you’re
targeting are the people that would have had good
behaviours anyway. I suppose who you’re trying to get
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know, ‘Oh yeah, okay, actually, that makes sense.
That’s something I should do.’
(Adult Female Interview 11)Follow up communication
Follow-up emails detailing the progress of the cam-
paign and asking the AGs for feedback on their own ac-
tions were requested. Follow up emails could
emphasise that the website is a resource as well as a
place to make pledges.
You could maybe send out an e-mail in February to
say [in sing-song voice], “The coughs and colds season’s
nearly over – how did you do with your pledge?” Or,
“Did you go to the doctor? Did you go to your phar-
macy?” And then maybe that’s where you offer the
feedback thing, actually. You could then maybe say
you know, “Let us know if you struggled with your
pledge,” or “Let us know how you met your pledge and
how you found it easy,” or … not easy, but what helps
you keep to it, type thing. ‘Cause it could be that you’d
get a bunch of e-mails saying, “Yeah, well, I didn’t get
a cold, so it was easy.” (Adult Female Interview 3)Discussion
This qualitative evaluation found that the Antibiotic
Guardian Campaign offered a framework to support
AGs pre-existing beliefs and provided an opportunity for
constructive collective action. This is in line with other
literature which suggests public campaigns have some
positive effects [6] and represent one component of
multi-level actions against AMR related issues. This
evaluation makes a useful contribution to the limited
evidence base on pledge-based interventions [20].
AGs recalled becoming aware of the campaign
through professional networks and social media. AGs
appeared engaged and concerned with the AMR issue
and were motivated to have an impact on AMR. How-
ever, despite receiving an automated email with the
pledge stated, most AGs could not recall their pledge.
Once prompted, many felt they had fulfilled their
pledges although this could reflect changing behaviour
in line with the pledge, or the pledge reflecting pre-
existing behaviour. Others suggested they had not had
an opportunity to perform the pledge (for example, by
not being ill). The campaign had also led to reflections
on AMR related behaviour and diffusion of its messages
to others. Although the campaign’s aim was viewed as
valuable and promising, its personal and wider impact
was unclear to AGs and thought to be limited by re-
stricted visibility and reach. In practice, this restricted
visibility can be explained by the absence of sufficientfunding to promote the campaign beyond social media
and press releases.
Similarities and differences in the findings from the
quantitative [10] and qualitative components of the
evaluation, and the PHE-led process evaluation, are
worthy of note. Unlike the quantitative evaluation,
which found that the majority of AGs could partially or
fully remember their pledge, only a minority of AGs
could recall their pledge during the interview. This may
reflect the greater length of time since signing up to
the qualitative compared to the quantitative evaluation
(10–16 months vs 5 months after the campaign
launched), or the different questions asked. The inter-
views asked AGs to report their exact pledge, whilst the
questionnaire asked if they could remember it. The
qualitative evaluation suggests the campaign had a
more subtle and nuanced impact on behaviour than the
quantitative evaluation which described self-reported
behaviour change in line with the pledge. The qualita-
tive evaluation suggests the campaign may have sup-
ported ongoing changes in behaviour such as
prescribing practices, contributed to small changes to
health-seeking (e.g. waiting for 5 days before going to
the doctor), or reinforced behaviour already aligning
with the pledge.
In line with the qualitative findings, the quantitative
evaluation also demonstrated that the majority of AGs
joined the campaign because of pre-existing awareness
of the importance of AMR. The qualitative work sup-
ports the quantitative finding that a lack of opportunity
to fulfil the pledge was an important reason for not ful-
filling it. This relates to the current study’s finding that
not developing pledge related symptoms (coughs, colds,
sore throats and flu) meant AG’s could not enact the
pledge. Both evaluations found mixed reports of acquir-
ing new knowledge through the campaign. The qualita-
tive evaluation builds on the quantitative finding that
AGs were willing to promote the campaign to friends,
family and colleagues by offering examples of how the
campaign has been promoted (e.g. displaying campaign
materials). The qualitative findings echo the process
evaluation regarding the channels through which AGs
become aware of the campaign: professional networks
and social media [11].
The campaign’s emphasis on collective action was a
motivator for signing up. The importance of collective
action to make “resistance visible as a societal threat”
has been recommended previously [4]. AGs also valued
the emphasis on collective action as opposed to blaming
certain individuals or groups for AMR. Attributing
blame for AMR among different professional groups, in-
cluding GPs, farmers and vets [23] as highlighted in this
research, is influenced by the unclear evidence on the
key drivers of AMR [4]. Brooks and colleagues found
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antibiotic resistance on other patients and GPs (in the
past) for misusing, overusing and prescribing
antibiotics [23].
This evaluation captured several accounts of activities
to promote the campaign and its messages. The cam-
paign was experienced by a few AGs as empowering
them to encourage and discuss the campaign issues with
others. This finding could relate to the ‘diffusion of
innovation’ theory in which new actions are spread
among members of a social system through communica-
tion with influential ‘early adopters’ [24]. It is not known
whether AGs are influential within their social groups,
and it was not within the scope of this evaluation to ex-
plore the impact of such diffusion. However, spreading
the campaign’s messages by recruiting popular and influ-
ential AGs may provide a mechanism for engaging those
with less knowledge about AMR. One suggestion from
this evaluation is to develop a nomination system for
AGs to encourage others to sign up to the campaign.
Other English Antibiotic Campaigns have found low
recollection of campaign materials [25]. AGs in this
evaluation struggled to recall their pledge but could re-
call the campaign’s message. A reminder system could
be developed to improve recollection of pledge mes-
sages. This would also encourage AGs to return to the
website and engage with campaign resources. Pledge re-
minders increased the effectiveness of an intervention
targeting healthy eating among school-age children [19].
Greater visibility of the campaign is also likely to be im-
portant in facilitating engagement and adherence with
pledges [12, 25, 26] and expanding the reach of the cam-
paign beyond those with a personal or professional inter-
est in AMR. However, enhanced visibility is likely to
require additional financial support.
An explanation for the limited perceived personal im-
pact of the campaign is the pre-existing AMR concern
among AGs. Therefore, the campaign may not have
reached those with an opportunity to modify their be-
haviour. Furthermore, the pledges may not have
reflected a goal to which AGs were previously commit-
ted but were not achieving, which is fundamental to the
‘intention-behaviour’ gap theory underpinning the cam-
paign. To address this issue, the campaign could develop
a system for helping AGs identify an individually tai-
lored, currently unachieved goal to create an appropriate
‘if-then’ scenario [20].
Strengths and limitations
A strength of this evaluation is the inclusion of a diverse
sample reflecting several AG pledge groups and pledges.
This allowed the elucidation of campaign experiences
from multiple perspectives. However, we experienced a
low recruitment rate and the diverse number of pledgegroups sampled meant it was not possible to achieve
theoretical saturation, when no additional new infor-
mation is attained [12], across all themes. As noted,
the recruited sample contained a higher proportion of
female AGs and a lower proportion of HCPs than the
full cohort [11], therefore it is possible that the views
and experiences of this sample do not reflect those of
the full cohort. In addition, our sample does not reflect
all possible pledge groups and so there is a potential
that these unrepresented groups may have experienced
the campaign differently, however this is unlikely given
the diverse sample achieved and the similarity of
responses.
The qualitative methods used in this evaluation com-
plement and facilitate the interpretation of the quanti-
tative evaluation, generating a more comprehensive
impression of campaign experiences. The qualitative
work was also conducted later than the quantitative
evaluation allowing us to explore the longer-term im-
pacts of the campaign.
Our study is inevitably affected by recall bias, there-
fore conclusions about the findings must be drawn
cautiously. As in the quantitative evaluation, acquies-
cence bias, whereby participants are aware of the
desired responses may have influenced responses, how-
ever, AGs suggested improvements to the campaign
and reports of the campaign having minimal impact
suggest this may not have occurred.Conclusions
This qualitative study makes an important contribu-
tion to understanding the impact of an innovative
online pledge-based campaign seeking to improve the
appropriate use of antibiotics. Campaign participation
led to some diffusion of campaign messages, behav-
ioural reflections, and evidence of the pledges being
accomplished although for many participants this
appeared to be through the reinforcement of existing
behaviour rather than behaviour change. In line with
the quantitative evaluation, we recommend that the
campaign be developed further to engage those with-
out pre-existing knowledge of AMR by increasing its
visibility, capitalising on the diffusion of the campaign’s
message through existing Antibiotic Guardians, par-
ticularly those with influence and, consider developing
an AG nomination system. The campaign could
include more awareness raising content, such as the
definition of AMR, for those with limited AMR know-
ledge. A system for reminding AGs of their pledge
could also be developed. Finally, the campaign could
develop a system for creating individually tailored
pledges relating to committed goals which are
currently not being achieved.
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